Ovid Therapeutics Inc (OVID) Stock Price, Quote & News

Company Profile

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 661 7661

Fax: 646 661 4027

Website: www.ovidrx.com

Address:

441 Ninth Avenue, 14th Floor, New York, United States

OfficialStocktwitsUser Feb. 3 at 9:52 PM

$OVID RSI: 44.44, MACD: -0.0163 Vol: 0.09, MA20: 1.64, MA50: 1.62 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

masonat Feb. 3 at 8:29 PM

$OVID Nice interview with Meg https://www.biotechtv.com/post/ovid-therapeutics-february2-2025

0 · Reply

REDWIR Jan. 30 at 9:18 AM

$OVID buy this now !! Huge green candle gains coming

0 · Reply

Tonydarien Jan. 30 at 2:40 AM

$OVID https://d18rn0p25nwr6d.cloudfront.net/CIK-0001636651/5b6aff34-e5b9-49c3-9aae-ba2b4150ac9f.pdf

1 · Reply

REDWIR Jan. 28 at 9:15 PM

$OVID looks like a test of 1.52, maybe even 1.40 before run to 1.92 then 2.58. Huge sell off today was trading shares to other investors not selling. Candles don’t lie.

1 · Reply

StockConsultant Jan. 28 at 1:00 PM

$OVID Ovid Therapeutics stock, watch for a narrow range breakout above 1.87

0 · Reply

foolforlove20 Jan. 27 at 8:27 PM

$OVID Let's get 2+to 2-5-7-11-16

0 · Reply

lawrence4270 Jan. 27 at 5:46 PM

$OVID Holding an avg of 1.60....waiting for our run....

1 · Reply

lucabrix Jan. 27 at 4:20 PM

$OVID Im not in a hurry, can wit till that damm 1.80 resistance will fall, and than

0 · Reply

zoneclassman1 Jan. 27 at 3:11 PM

$IPSC $IBRX $OVID Sparo on spot. I traded a lot of his pics, made my account big green so far!

2 · Reply

Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots

Dec 18, 2025, 8:00 AM EST - 6 weeks ago

Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)

Dec 2, 2025, 7:00 AM EST - 2 months ago

Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

Nov 12, 2025, 7:00 AM EST - 2 months ago

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

Oct 3, 2025, 12:52 PM EDT - 4 months ago

Ovid Therapeutics Inc. - Special Call

Oct 3, 2025, 7:05 AM EDT - 4 months ago

Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds

Oct 3, 2025, 7:00 AM EDT - 4 months ago

Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile

Aug 13, 2025, 8:00 AM EDT - 6 months ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results

Jul 23, 2025, 8:30 AM EDT - 6 months ago

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference

Jun 25, 2025, 8:00 AM EDT - 7 months ago

Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties

May 13, 2025, 8:00 AM EDT - 9 months ago

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Mar 11, 2025, 8:00 AM EDT - 11 months ago

Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 8:00 AM EST - 1 year ago

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

Feb 27, 2025, 8:00 AM EST - 1 year ago

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 5, 2025, 8:00 AM EST - 1 year ago

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Sep 11, 2024, 8:00 AM EDT - 1 year ago

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Aug 19, 2024, 11:00 AM EDT - 1 year ago

Shareholders In Ovid Therapeutics Inc Invited To Participate In Fraud Investigation With The Schall Law Firm

Aug 18, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Encouraged To Join Fraud Investigation With Schall Law Firm

Aug 17, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Eligible To Participate In Fraud Investigation With Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Invited To Join In Fraud Investigation With Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Encouraged To Join Fraud Investigation With Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Invited To Join Fraud Investigation With Schall Law Firm

Aug 14, 2024, 1:15 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Welcome To Participate In Fraud Investigation With Schall Law Firm

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Aug 12, 2024, 11:55 PM EDT - 1 year ago

Ovid Therapeutics Inc Investors Invited To Join Fraud Investigation With Schall Law Firm

Aug 9, 2024, 9:15 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Can Participate In Fraud Investigation With The Schall Law Firm

Aug 8, 2024, 4:00 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Eligible To Join Fraud Investigation With The Schall Law Firm

Aug 7, 2024, 11:30 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Can Join Fraud Investigation With The Schall Law Firm

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Ovid Therapeutics Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

Aug 2, 2024, 10:00 AM EDT - 1 year ago

OVID Investors Have Opportunity to Join Ovid Therapeutics Inc. Fraud Investigation with the Schall Law Firm

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at Upcoming August Investor Conferences

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists

Jul 1, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

Jun 17, 2024, 8:58 AM EDT - 1 year ago

What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?

TAK

Jun 17, 2024, 6:55 AM EDT - 1 year ago

Ovid Therapeutics Reports on Takeda's Announcement of Phase 3 Topline Study Results for Soticlestat

May 14, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results

May 13, 2024, 7:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Apr 9, 2024, 10:48 AM EDT - 1 year ago

Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024

Apr 4, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 8, 2024, 8:00 AM EST - 2 years ago

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results

Feb 28, 2024, 8:00 AM EST - 2 years ago

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Feb 6, 2024, 8:00 AM EST - 2 years ago

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dec 1, 2023, 7:30 AM EST - 2 years ago

Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates

Oct 18, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026

OfficialStocktwitsUser Feb. 3 at 9:52 PM

0 · Reply

masonat Feb. 3 at 8:29 PM

$OVID Nice interview with Meg https://www.biotechtv.com/post/ovid-therapeutics-february2-2025

0 · Reply

REDWIR Jan. 30 at 9:18 AM

$OVID buy this now !! Huge green candle gains coming

0 · Reply

Tonydarien Jan. 30 at 2:40 AM

$OVID https://d18rn0p25nwr6d.cloudfront.net/CIK-0001636651/5b6aff34-e5b9-49c3-9aae-ba2b4150ac9f.pdf

1 · Reply

REDWIR Jan. 28 at 9:15 PM

$OVID looks like a test of 1.52, maybe even 1.40 before run to 1.92 then 2.58. Huge sell off today was trading shares to other investors not selling. Candles don’t lie.

1 · Reply

StockConsultant Jan. 28 at 1:00 PM

$OVID Ovid Therapeutics stock, watch for a narrow range breakout above 1.87

0 · Reply

foolforlove20 Jan. 27 at 8:27 PM

$OVID Let's get 2+to 2-5-7-11-16

0 · Reply

lawrence4270 Jan. 27 at 5:46 PM

$OVID Holding an avg of 1.60....waiting for our run....

1 · Reply

lucabrix Jan. 27 at 4:20 PM

$OVID Im not in a hurry, can wit till that damm 1.80 resistance will fall, and than

0 · Reply

zoneclassman1 Jan. 27 at 3:11 PM

$IPSC $IBRX $OVID Sparo on spot. I traded a lot of his pics, made my account big green so far!

2 · Reply

michaelhearn Jan. 25 at 5:35 PM

$OVID we should start building to 5 on any volume or positives. Got to crack through that 1.80 area first though

1 · Reply

lucabrix Jan. 22 at 8:26 PM

$OVID damn resistance, get down!!

0 · Reply

Arodrcp Jan. 21 at 10:43 PM

$OVID stop playing gurl

0 · Reply

Tonydarien Jan. 21 at 9:42 PM

$OVID nice rebound

0 · Reply

Devante14 Jan. 15 at 3:08 PM

$OVID can this do something already

0 · Reply

Pay4school Jan. 15 at 5:34 AM

$OVID

1 · Reply

kayeffdubb Jan. 10 at 2:15 AM

$OVID can someone explain what this graph means?

3 · Reply

REDWIR Jan. 6 at 9:28 PM

$OVID technically holding highs of October it’s coiling up for a big move up . $2 soon

2 · Reply

OpenOutcrier Jan. 6 at 1:57 PM

$OVID (+4.2% pre) Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P. https://ooc.bz/l/88729

0 · Reply

SofaKing_Nuts Jan. 5 at 10:06 PM

$OVID new 13G Point72 up to 5.1% now

0 · Reply

StockConsultant Jan. 5 at 1:23 PM

$OVID therapeutics stock, strong day, watch for a top of range breakout

0 · Reply

BiodegradableBurger Dec. 29 at 3:56 PM

$OVID Did we kill a dog? Down 8% for?

2 · Reply

Market Cap	111.09M
Revenue (ttm)	570,000.00
Net Income (ttm)	-26.43M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,636.84%
Debt to Equity Ratio	0.00

Volume	1,912,900
Avg Vol	1,713,294
Day's Range	N/A - N/A
Shares Out	71.21M
Stochastic %K	26%
Beta	0.22
Analysts	Strong Sell
Price Target	$4.16